Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Clinical trial NCT01048671 · COMPLETED
Trial details
- NCT number
- NCT01048671
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2010-01-01
- Primary completion
- 2012-12-01
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.